Patent: 5,844,099
✉ Email this page to a colleague
Summary for Patent: 5,844,099
Title: | Cytokine antagonists |
Abstract: | Heteromeric proteins comprising a soluble .alpha. specificity determining cytokine receptor component and the extracellular domain of a .beta. receptor component function as cytokine antagonists. |
Inventor(s): | Stahl; Neil (Carmel, NY), Economides; Aris (Dobbs Ferry, NY), Yancopoulos; George D. (Yorktown Heights, NY) |
Assignee: | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) |
Application Number: | 08/563,105 |
Patent Claims: | see list of patent claims |
Details for Patent 5,844,099
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals (uk), Ltd. | ARCALYST | rilonacept | For Injection | 125249 | 02/27/2008 | ⤷ Try a Trial | 2013-10-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,844,099
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 948242 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9511303 | ⤷ Try a Trial |
United States of America | 5470952 | ⤷ Try a Trial |
Portugal | 726954 | ⤷ Try a Trial |
Japan | H09504030 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |